Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year guidance.
Third-quarter revenue increased modestly to $10.60 billion from $10.57 billion in the comparable period last yearEarnings, on a reported basis, declined to $4.25 in the September quarter from $4.42 in the year-ago quarterOn an adjusted basis, Q3 earnings dropped to $5.28 per share from $5.69 per share in the third quarter of 2023Operating income for the third quarter was $1.84 billion, compared to $1.86 billion in the year-ago quarterThe company raised its full-year EPS guidance to the range of $21.35 to $22.07 from the previous guidance of $21.29 to $22.07It continues to expect fiscal 2024 revenue to be between $42.4 billion and $43.3 billion
The post Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
